SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-006813
Filing Date
2018-05-24
Accepted
2018-05-24 08:10:28
Documents
17
Period of Report
2018-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k040918_immudyneinc.htm 8-K 26226
2 PRESENTATION MATERIAL f8k040918ex99-1_immudyne.htm EX-99.1 12723
3 GRAPHIC slide1.jpg GRAPHIC 73995
4 GRAPHIC slide2.jpg GRAPHIC 101257
5 GRAPHIC slide3.jpg GRAPHIC 56378
6 GRAPHIC slide4.jpg GRAPHIC 81583
7 GRAPHIC slide5.jpg GRAPHIC 45602
8 GRAPHIC slide6.jpg GRAPHIC 61636
9 GRAPHIC slide7.jpg GRAPHIC 13672
10 GRAPHIC slide8.jpg GRAPHIC 55026
11 GRAPHIC slide9.jpg GRAPHIC 66709
12 GRAPHIC slide10.jpg GRAPHIC 69227
13 GRAPHIC slide11.jpg GRAPHIC 65668
14 GRAPHIC slide12.jpg GRAPHIC 71018
15 GRAPHIC slide13.jpg GRAPHIC 65016
16 GRAPHIC slide14.jpg GRAPHIC 62099
17 GRAPHIC slide15.jpg GRAPHIC 34123
  Complete submission text file 0001213900-18-006813.txt   1312988
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18856671
SIC: 2833 Medicinal Chemicals & Botanical Products